Page last updated: 2024-09-04

cyc 202 and Leukemia L 1210

cyc 202 has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blow, JJ; Borgne, A; Chong, JP; Delcros, JG; Inagaki, M; Inagaki, N; Meijer, L; Moulinoux, JP; Mulner, O1

Other Studies

1 other study(ies) available for cyc 202 and Leukemia L 1210

ArticleYear
Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    European journal of biochemistry, 1997, Jan-15, Volume: 243, Issue:1-2

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Calcium-Calmodulin-Dependent Protein Kinases; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Enzyme Inhibitors; Growth Inhibitors; Humans; Kinetin; Leukemia L1210; Maturation-Promoting Factor; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Oogenesis; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Purines; Roscovitine; Sea Urchins; Starfish; Substrate Specificity; Vimentin; Xenopus laevis; Xenopus Proteins

1997